These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
332 related articles for article (PubMed ID: 20811799)
41. Kynurenine inhibits melanogenesis in human melanocyte-keratinocyte co-cultures and in a reconstructed 3D skin model. Ferreira Branquinho MS; Silva MBB; Castilho GA; Cavalcante J; Barros SBM; Clara RO; Maria-Engler SS; Campa A Exp Dermatol; 2022 Mar; 31(3):427-432. PubMed ID: 34710259 [TBL] [Abstract][Full Text] [Related]
42. Abnormal kynurenine pathway of tryptophan catabolism in cardiovascular diseases. Song P; Ramprasath T; Wang H; Zou MH Cell Mol Life Sci; 2017 Aug; 74(16):2899-2916. PubMed ID: 28314892 [TBL] [Abstract][Full Text] [Related]
43. Accelerated kynurenine pathway downregulates immune activation in patients with axial spondyloarthritis. Yurt EF; Biçer C; Serdar MA; Akan S; Erten Ş Cytokine; 2023 Sep; 169():156247. PubMed ID: 37295242 [TBL] [Abstract][Full Text] [Related]
44. High-affinity uptake of kynurenine and nitric oxide-mediated inhibition of indoleamine 2,3-dioxygenase in bone marrow-derived myeloid dendritic cells. Hara T; Ogasawara N; Akimoto H; Takikawa O; Hiramatsu R; Kawabe T; Isobe K; Nagase F Immunol Lett; 2008 Feb; 116(1):95-102. PubMed ID: 18179826 [TBL] [Abstract][Full Text] [Related]
45. Associations Among Obesity, Inflammation, and Tryptophan Catabolism in Pregnancy. Groer M; Fuchs D; Duffy A; Louis-Jacques A; D'Agata A; Postolache TT Biol Res Nurs; 2018 May; 20(3):284-291. PubMed ID: 29141444 [TBL] [Abstract][Full Text] [Related]
46. Indoleamine 2,3-dioxygenase (IDO)-activity in Severe Psychiatric Disorders: A Systemic Review. Fellendorf FT; Bonkat N; Dalkner N; Schönthaler EMD; Manchia M; Fuchs D; Reininghaus EZ Curr Top Med Chem; 2022; 22(25):2107-2118. PubMed ID: 35850653 [TBL] [Abstract][Full Text] [Related]
47. Interaction of the immune-inflammatory and the kynurenine pathways in rats resistant to antidepressant treatment in model of depression. Duda W; Curzytek K; Kubera M; Connor TJ; Fagan EM; Basta-Kaim A; Trojan E; Papp M; Gruca P; Budziszewska B; Leśkiewicz M; Maes M; Lasoń W Int Immunopharmacol; 2019 Aug; 73():527-538. PubMed ID: 31176083 [TBL] [Abstract][Full Text] [Related]
49. Involvement of the microbiota-gut-brain axis in chronic restraint stress: disturbances of the kynurenine metabolic pathway in both the gut and brain. Deng Y; Zhou M; Wang J; Yao J; Yu J; Liu W; Wu L; Wang J; Gao R Gut Microbes; 2021; 13(1):1-16. PubMed ID: 33535879 [TBL] [Abstract][Full Text] [Related]
50. Does tryptophan degradation along the kynurenine pathway mediate the association between pro-inflammatory immune activity and depressive symptoms? Quak J; Doornbos B; Roest AM; Duivis HE; Vogelzangs N; Nolen WA; Penninx BW; Kema IP; de Jonge P Psychoneuroendocrinology; 2014 Jul; 45():202-10. PubMed ID: 24845191 [TBL] [Abstract][Full Text] [Related]
51. LC-MS/MS-based quantification of kynurenine metabolites, tryptophan, monoamines and neopterin in plasma, cerebrospinal fluid and brain. Fuertig R; Ceci A; Camus SM; Bezard E; Luippold AH; Hengerer B Bioanalysis; 2016 Sep; 8(18):1903-17. PubMed ID: 27524289 [TBL] [Abstract][Full Text] [Related]
52. Effects of immune activation on quinolinic acid and neuroactive kynurenines in the mouse. Saito K; Markey SP; Heyes MP Neuroscience; 1992 Nov; 51(1):25-39. PubMed ID: 1465184 [TBL] [Abstract][Full Text] [Related]
53. Cell cycle arrest by kynurenine in lens epithelial cells. Mailankot M; Smith D; Howell S; Wang B; Jacobberger JW; Stefan T; Nagaraj RH Invest Ophthalmol Vis Sci; 2008 Dec; 49(12):5466-75. PubMed ID: 18676626 [TBL] [Abstract][Full Text] [Related]
55. The role of tryptophan metabolism in iNOS transcription and nitric oxide production by chicken macrophage cells upon treatment with interferon gamma. Kujundzić RN; Lowenthal JW Immunol Lett; 2008 Jan; 115(2):153-9. PubMed ID: 18082271 [TBL] [Abstract][Full Text] [Related]
56. Kynurenine and uric acid levels in chronic myeloid leukemia patients. Vonka V; Humlova Z; Klamova H; Kujovska-Krcmova L; Petrackova M; Hamsikova E; Krmencikova-Fliegl M; Duskova M; Roth Z Oncoimmunology; 2015 Mar; 4(3):e992646. PubMed ID: 25949913 [TBL] [Abstract][Full Text] [Related]
57. Dramatic changes in oxidative tryptophan metabolism along the kynurenine pathway in experimental cerebral and noncerebral malaria. Sanni LA; Thomas SR; Tattam BN; Moore DE; Chaudhri G; Stocker R; Hunt NH Am J Pathol; 1998 Feb; 152(2):611-9. PubMed ID: 9466588 [TBL] [Abstract][Full Text] [Related]
58. Association of plasma kynurenine pathway metabolite concentrations with metabolic health risk in prepubertal Asian children. Tan KM; Tint MT; Kothandaraman N; Yap F; Godfrey KM; Lee YS; Tan KH; Gluckman PD; Chong YS; Chong MFF; Eriksson JG; Cameron-Smith D Int J Obes (Lond); 2022 Jun; 46(6):1128-1137. PubMed ID: 35173282 [TBL] [Abstract][Full Text] [Related]
59. Kynurenine, Tetrahydrobiopterin, and Cytokine Inflammatory Biomarkers in Individuals Affected by Diabetic Neuropathic Pain. Staats Pires A; Heng B; Tan VX; Latini A; Russo MA; Santarelli DM; Bailey D; Wynne K; O'Brien JA; Guillemin GJ; Austin PJ Front Neurosci; 2020; 14():890. PubMed ID: 32973438 [TBL] [Abstract][Full Text] [Related]